CardiacAssist, a US-based medical device company,has introduced the Protek17 arterial cannula, a key component of the TandemHeart temporary circulatory support platform with new features designed to improve patient safety during temporary circulatory support.
Protek17 arterial cannula is designed to improve patient safety with new features including suture wings for secure attachment to the patient and a rubber stop to prevent over-insertion.
The Protek17 cannula is cleared from the US Food and Drug Administration and has been successfully used in multiple TandemHeart cases during a limited commercial release in 2013.
CardiacAssist president and CEO John Marous noted the Protek17 cannula represents a major milestone for the company and is the first in a family of products it plans to launch in the near future.
"We will continue to focus on new product development and the advancement of clinical science to improve the quality of circulatory support therapy across a wide spectrum of patient needs," Marous added.
TandemHeart system's left atrial cannulation makes a fully percutaneous extracorporeal blood circuit to bypass the left ventricle, increasing blood flow by up to 5.0L/min.
